Search
SOLACI Congress
Presentations

Implante Valvular Aórtico Percutáneo: Partner 5 años

solaci
solaci
20
0
16_daniel_berrocal

By: Daniel Berrocal, MD, PhD, MTSAC, FACC
Jefe de Cardiología Intervencionista.
Hospital Italiano. Buenos Aires

Previous article
MANEJO DE LA INSUFICIENCIA CARDIACA CON FE PRESERVADA
Next article
Efectos Renales de los Antihipertensivos
solaci
solaci

More articles by this author

Recambio valvular aórtico tradicional: PARTNER 5 anos

solaci - 0
By: Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil

Estenosis aórtica severa con bajo flujo, bajo gradiente y disfunción sistólica

solaci - 0
By: Rubén G. Servián C. MD Departamento de Imágenes – Hospital Central Instituto de Previsión Social (I.P.S.)

Prevención de la enfermedad cardiovascular y ejercicio físico en el adulto: ¿ una cuestión de intensidad?

solaci - 0
By: Dra. María Carolina Acosta Cazal

Angioplastía en Tronco coronario izquierdo y Enfermedad de Múltiples Vasos. Nuevas evidencias 2015.

solaci - 0
By: Dr. Marcelo Halac Hospital Italiano - Buenos Aires

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Presentations

Recambio valvular aórtico tradicional: PARTNER 5 anos

By: Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil
solaci -
SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy